MARISSA TORRES: Open Payments
NPI 1285199794 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,779 in 118 payments from 37 companies in 2025. Trend: 2023 $2,555 · 2024 $2,766 · 2025 $2,779
Food & beverage: $2,779
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $363 |
| Axsome Therapeutics, Inc. | 13 | $300 |
| UCB, Inc. | 7 | $196 |
| Biogen, Inc. | 8 | $191 |
| Otsuka America Pharmaceutical, Inc. | 6 | $154 |
| PFIZER INC. | 6 | $143 |
| Neurelis, Inc. | 6 | $119 |
| Lundbeck LLC | 4 | $113 |
| Neurocrine BioSciences, Inc. | 4 | $108 |
| JAZZ PHARMACEUTICALS INC. | 3 | $91 |
Products named: QULIPTA, REXULTI, Sunosi, TYSABRI, VALTOCO, INGREZZA, NURTEC ODT, EPIDIOLEX.
Industry payments across GA — which companies pay providers there.
